Literature DB >> 29800967

Association Between Vessel Density and Visual Acuity in Patients With Diabetic Retinopathy and Poorly Controlled Type 1 Diabetes.

Bénédicte Dupas1, Wilfried Minvielle1, Sophie Bonnin1, Aude Couturier1, Ali Erginay1, Pascale Massin1, Alain Gaudric1, Ramin Tadayoni1.   

Abstract

Importance: Capillary dropout is a hallmark of diabetic retinopathy, but its role in visual loss remains unclear. Objective: To examine how macular vessel density is correlated with visual acuity (VA) in patients younger than 40 years who have type 1 diabetes without macular edema but who have diabetic retinopathy requiring panretinal photocoagulation. Design, Settings, and Participants: Retrospective cohort study of VA and optical coherence tomography angiography data collected from consecutive patients during a single visit to Lariboisière Hospital, a tertiary referral center in Paris, France. The cohort included 22 eyes of 22 patients with type 1 diabetes without macular edema but with bilateral rapidly progressive diabetic retinopathy that was treated with panretinal photocoagulation between August 15, 2015, and December 30, 2016. Eyes were classified into 2 groups by VA: normal (logMAR, 0; Snellen equivalent, 20/20) and decreased (logMAR, >0; Snellen equivalent, <20/20). The control group included 12 eyes from age-matched healthy participants with normal vision. Main Outcomes and Measures: Visual acuity and mean vessel density in 4 retinal vascular plexuses: the superficial vascular plexus and the deep capillary complex, which comprises the intermediate capillary plexus and the deep capillary plexus.
Results: Of the 22 participants, 11 (50%) were men, mean (SD) age was 30 (6) years, and mean (SD) hemoglobin A1c level was 8.9% (1.6%). Of the 22 eyes with diabetic retinopathy, 13 (59%) had normal VA and 9 (41%) had decreased VA (mean [SD]: logMAR, 0.12 [0.04]; Snellen equivalent, 20/25). Mean [SE] vessel density was lower for eyes with diabetic retinopathy and normal VA compared with the control group in the superficial vascular plexus (44.1% [0.9%] vs 49.1% [0.9%]; difference, -5.0% [1.3%]; 95% CI, -7.5% to -2.4%; P < .001), in the deep capillary complex (44.3% [1.2%] vs 50.6% [1.3%]; difference, -6.3% [1.8%]; 95% CI, -9.9% to -2.7%; P = .001), in the intermediate capillary plexus (43.8% [1.2%] vs 49.3% [1.2%]; difference, -5.5% [1.7%]; 95% CI, -9.0% to -2.0%; P = .003), and in the deep capillary plexus (24.5% [1.0%] vs 30.5% [1.0%]; difference, -6.1% [1.4%]; 95% CI, -8.9% to -3.2%; P < .001). Mean vessel density was lower in eyes with diabetic retinopathy and decreased VA compared with eyes with diabetic retinopathy and normal VA; the mean (SE) loss was more pronounced in the deep capillary complex (34.6% [1.5%] vs 44.3% [1.2%]; difference, -9.6% [1.9%]; 95% CI, -13.6% to -5.7%; P < .001), especially in the deep capillary plexus (15.2% [1.2%] vs 24.5% [1.0%]; difference, -9.3% [1.5%]; 95% CI, -12.4% to -6.1%; P < .001), than in the superficial vascular plexus (39.6% [1.1%] vs 44.1% [0.9%]; difference, -4.5% [1.4%]; 95% CI, -7.3% to -1.7%; P = .002). Conclusions and Relevance: These data suggest that in patients with type 1 diabetes without macular edema but with severe nonproliferative or proliferative diabetic retinopathy, decreased VA may be associated with the degree of capillary loss in the deep capillary complex.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29800967      PMCID: PMC6136049          DOI: 10.1001/jamaophthalmol.2018.1319

Source DB:  PubMed          Journal:  JAMA Ophthalmol        ISSN: 2168-6165            Impact factor:   7.389


  41 in total

1.  Neurovascular crosstalk between interneurons and capillaries is required for vision.

Authors:  Yoshihiko Usui; Peter D Westenskow; Toshihide Kurihara; Edith Aguilar; Susumu Sakimoto; Liliana P Paris; Carli Wittgrove; Daniel Feitelberg; Mollie S H Friedlander; Stacey K Moreno; Michael I Dorrell; Martin Friedlander
Journal:  J Clin Invest       Date:  2015-04-27       Impact factor: 14.808

Review 2.  On the relationship between visual acuity and central retinal (macular) thickness after interventions for macular oedema in diabetics: a review.

Authors:  Anna Bong; Michael J Doughty; Norman F Button; David C Mansfield
Journal:  Clin Exp Optom       Date:  2016-06-19       Impact factor: 2.742

3.  Optical Coherence Tomography Angiography in Diabetic Retinopathy: A Prospective Pilot Study.

Authors:  Akihiro Ishibazawa; Taiji Nagaoka; Atsushi Takahashi; Tsuneaki Omae; Tomofumi Tani; Kenji Sogawa; Harumasa Yokota; Akitoshi Yoshida
Journal:  Am J Ophthalmol       Date:  2015-04-18       Impact factor: 5.258

4.  Quantifying Retinal Microvascular Changes in Uveitis Using Spectral-Domain Optical Coherence Tomography Angiography.

Authors:  Alice Y Kim; Damien C Rodger; Anoush Shahidzadeh; Zhongdi Chu; Nicole Koulisis; Bruce Burkemper; Xuejuan Jiang; Kathryn L Pepple; Ruikang K Wang; Carmen A Puliafito; Narsing A Rao; Amir H Kashani
Journal:  Am J Ophthalmol       Date:  2016-09-02       Impact factor: 5.258

5.  Macular thickness measurements in healthy eyes using six different optical coherence tomography instruments.

Authors:  Ute E K Wolf-Schnurrbusch; Lala Ceklic; Christian K Brinkmann; Milko E Iliev; Manuel Frey; Simon P Rothenbuehler; Volker Enzmann; Sebastian Wolf
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-02-21       Impact factor: 4.799

6.  CHARACTERIZATION OF THE MIDDLE CAPILLARY PLEXUS USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY IN HEALTHY AND DIABETIC EYES.

Authors:  Justin J Park; Brian T Soetikno; Amani A Fawzi
Journal:  Retina       Date:  2016-11       Impact factor: 4.256

Review 7.  Interrelationships between the Retinal Neuroglia and Vasculature in Diabetes.

Authors:  Timothy S Kern
Journal:  Diabetes Metab J       Date:  2014-06       Impact factor: 5.376

8.  Visualization of changes in the foveal avascular zone in both observed and treated diabetic macular edema using optical coherence tomography angiography.

Authors:  Aditya Gill; Emily D Cole; Eduardo A Novais; Ricardo N Louzada; Talisa de Carlo; Jay S Duker; Nadia K Waheed; Caroline R Baumal; Andre J Witkin
Journal:  Int J Retina Vitreous       Date:  2017-06-19

9.  Detailed Vascular Anatomy of the Human Retina by Projection-Resolved Optical Coherence Tomography Angiography.

Authors:  J P Campbell; M Zhang; T S Hwang; S T Bailey; D J Wilson; Y Jia; D Huang
Journal:  Sci Rep       Date:  2017-02-10       Impact factor: 4.379

10.  The effects of macular ischemia on visual acuity in diabetic retinopathy.

Authors:  Dawn A Sim; Pearse A Keane; Javier Zarranz-Ventura; Simon Fung; Michael B Powner; Elise Platteau; Catey V Bunce; Marcus Fruttiger; Praveen J Patel; Adnan Tufail; Catherine A Egan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-03-28       Impact factor: 4.799

View more
  30 in total

1.  Correlation of Quantitative Measurements with Diabetic Disease Severity Using Multiple En Face OCT Angiography Image Averaging.

Authors:  Jesse J Jung; Daryle Jason G Yu; Anne Zeng; Michael H Chen; Yue Shi; Marco Nassisi; Kenneth M Marion; Srinivas R Sadda; Quan V Hoang
Journal:  Ophthalmol Retina       Date:  2020-05-07

2.  MULTISCALE CORRELATION OF MICROVASCULAR CHANGES ON OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY WITH RETINAL SENSITIVITY IN DIABETIC RETINOPATHY.

Authors:  Emily S Levine; Eric M Moult; Eugenia Custo Greig; Yi Zhao; Varsha Pramil; Isaac Gendelman; Agha Y Alibhai; Caroline R Baumal; Andre J Witkin; Jay S Duker; James G Fujimoto; Nadia K Waheed
Journal:  Retina       Date:  2022-02-01       Impact factor: 4.256

3.  Quantitative analysis of early retinal vascular changes in type 2 diabetic patients without clinical retinopathy by optical coherence tomography angiography.

Authors:  Muhammed Altinisik; Neslihan Sinim Kahraman; Emin Kurt; Huseyin Mayali; Ozcan Kayikcioglu
Journal:  Int Ophthalmol       Date:  2022-01-31       Impact factor: 2.031

4.  Optical coherence tomography angiography for quantitative microvascular assessment in diabetic retinopathy: inter-device and intra-device agreement and correlation with clinical staging.

Authors:  Emanuele Crincoli; Donato Colantuono; Zhanlin Zhao; Eric H Souied; Alexandra Miere
Journal:  Acta Diabetol       Date:  2022-07-05       Impact factor: 4.087

5.  Automated machine learning-based classification of proliferative and non-proliferative diabetic retinopathy using optical coherence tomography angiography vascular density maps.

Authors:  Elias Khalili Pour; Khosro Rezaee; Hossein Azimi; Seyed Mohammad Mirshahvalad; Behzad Jafari; Kaveh Fadakar; Hooshang Faghihi; Ahmad Mirshahi; Fariba Ghassemi; Nazanin Ebrahimiadib; Masoud Mirghorbani; Fatemeh Bazvand; Hamid Riazi-Esfahani; Mohammad Riazi Esfahani
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2022-09-02       Impact factor: 3.535

6.  Evaluation of the retinal and choroidal microvasculature changes in cases of sarcoid and tuberculosis-associated posterior uveitis using OCT angiography.

Authors:  Lameece Moustafa Hassan; Ashgan Asaad; Zeinab ElSanabary; Maha M Youssef
Journal:  Int Ophthalmol       Date:  2022-08-27       Impact factor: 2.029

7.  Geometric Perfusion Deficits: A Novel OCT Angiography Biomarker for Diabetic Retinopathy Based on Oxygen Diffusion.

Authors:  Siyu Chen; Eric M Moult; Linda M Zangwill; Robert N Weinreb; James G Fujimoto
Journal:  Am J Ophthalmol       Date:  2020-09-09       Impact factor: 5.258

Review 8.  Advances in Retinal Imaging and Applications in Diabetic Retinopathy Screening: A Review.

Authors:  Beau J Fenner; Raymond L M Wong; Wai-Ching Lam; Gavin S W Tan; Gemmy C M Cheung
Journal:  Ophthalmol Ther       Date:  2018-11-10

9.  VESSEL DENSITY OF SUPERFICIAL, INTERMEDIATE, AND DEEP CAPILLARY PLEXUSES USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY.

Authors:  Carlo Lavia; Sophie Bonnin; Milena Maule; Ali Erginay; Ramin Tadayoni; Alain Gaudric
Journal:  Retina       Date:  2019-02       Impact factor: 4.256

10.  Systemic hypertension associated retinal microvascular changes can be detected with optical coherence tomography angiography.

Authors:  Christopher Sun; Carlo Ladores; Jimmy Hong; Duc Quang Nguyen; Jacqueline Chua; Daniel Ting; Leopold Schmetterer; Tien Yin Wong; Ching-Yu Cheng; Anna C S Tan
Journal:  Sci Rep       Date:  2020-06-12       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.